港股上市的归创通桥(02190.HK)自2012年成立以来实现了首次年度盈利。据公司3月20日发布的业绩报告,公司2024年实现营业收入7.8亿元,同比增长48.3%;净利润突破1亿元。归创通桥主营外周血管介入和神经血管介入业务。2024年,公司介入产品收入的67.7%来自神经血管介入产品业务,32.3%来自外周血管介入产品业务。公司收入增长,也主要源于这两块业务销售额增加。在3月21日上午进行的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.